thromboxan biosynthesi cardiovascular diseas sudden fissur atherosclerot plaqu primari trigger transient spontan ischemia coronari cerebr circul measur urinari result aspirin trial episod platelet activ site acut vascular lesion thromboxan TX biosynthesi episod increas metabolit excret unstabl angina aspirin mg/day third fatal nonfat thrombot event set similar dynam thrombot process earli phase acut myocardi infarct thromboxan metabolit measur result trial similar impact short-term aspirin therapi unstabl angina percutan translumin coronari angioplasti biosynthesi aspirin-suppress periprocedur thrombot complic hand non-insulin-depend diabet mellitu type iia hypercholesterolemia reproduc abnorm platelet function associ like system stimulu activ continu episod alter low-dos mg/day aspirin thromboxan metabolit excret diseas low-dos aspirin and/or select prostaglandin antagonist import tool hypothesi platelet activ import transduc enhanc thrombot risk metabol abnorm 